Emerging strategies and translational advancements of DDR1 in oncology

Abstract Discoidin domain receptor 1 (DDR1) has emerged as a promising therapeutic target in oncology due to its unique role in tumor-stroma interactions and its involvement in key signaling pathways that drive cancer progression. DDR1 is homologous to the transmembrane receptor tyrosine kinase (RTK...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuxi Luo, Tianxin Liu, Jinli Pei, Shengnan Xu, Jie Liu, Jinming Yu
Format: Article
Language:English
Published: Springer 2025-03-01
Series:Discover Oncology
Subjects:
Online Access:https://doi.org/10.1007/s12672-025-02107-z
Tags: Add Tag
No Tags, Be the first to tag this record!